Nucleic acids encoding opiate receptors
View Patent ↗The invention provides isolated nucleic acid molecules, host cells that contain an isolated nucleic acid molecule, and substantially pure polypeptides. For example, the invention provides isolated nucleic acid molecules that encode polypeptides having mu3 opiate receptor activity, host cells that contain an isolated nucleic acid molecule that encodes a polypeptide having mu3 opiate receptor activity, and substantially pure polypeptides that have mu3 opiate receptor activity. In addition, the invention provides methods and materials for identifying mu3 opiate receptor agonists and antagonists.
1. An isolated nucleic acid primer for amplifying nucleic acid encoding a sequence of mu3 opiate receptor having higher affinity for morphine than for DAMGO, wherein said primer comprises at least a 15 contiguous nucleotide sequence set forth in SEQ ID NO:1 with or without a single nucleotide insertion, single nucleotide deletion, or single nucleotide substitution.
2. The primer of claim 1 , wherein said at least a 15 nucleotide sequence is set forth in SEQ ID NO:1 without an insertion, deletion, or substitution.
3. The primer of claim 1 , wherein said at least a 15 nucleotide sequence is set forth in SEQ ID NO:1 with a single nucleotide insertion.
4. The primer of claim 1 , wherein said at least a 15 nucleotide sequence is set forth in SEQ ID NO:1 with a single nucleotide deletion.
5. The primer of claim 1 , wherein said at least a 15 nucleotide sequence is set forth in SEQ ID NO:1 with a single nucleotide substitution.
6. The primer of claim 1 , wherein said at least a 15 nucleotide sequence is between 15 and 30 nucleotides in length.